P. R. Ashton et al. / Tetrahedron 57 (2001) 947±956
955
lene (11). To a solution of 4 (0.75 g, 1.4 mmol) in DMF
(120 mL) was added a solution of CsOH´H2O (1.03 g,
6.1 mmol) in MeOH (15 mL) during 10 min. The mixture
was stirred for 1 h, whereupon 6 (2.40 g, 6.1 mmol) in DMF
(20 mL) was added. After stirring for 3 h, the mixture was
concentrated in vacuo. The product was dissolved in CH2Cl2
(200 mL), washed with water (2£200 mL), and dried
(MgSO4). After ®ltration, the solution was boiled with
active charcoal for 5 min, ®ltered and concentrated in
vacuo. The product was subjected to column chroma-
tography [(i) CH2Cl2 elutes excess 7, (ii) CH2Cl2/EtOAc
10:1], affording 11 (1.69 g, 78%) as an orange semicrystal-
OCH2), 3.74 (t, J6.1 Hz, 4H, OCH2), 3.79±3.81 (m, 4H,
OCH2), 3.90 (t, J4.5 Hz, 4H, OCH2), 4.16 (t,
J4.5 Hz, 4H, OCH2), 6.90 (2£s, 4H, cat.); 13C NMR
(CDCl3): d36.21 (SCH2), 69.25 (OCH2), 69.71 (OCH2),
69.90 (OCH2), 70.77 (OCH2), 70.91 (OCH2), 114.32 (cat.),
121.53 (cat.), 127.64 (CvC), 148.91 (cat.), 189.66 (CvO);
FABMS: m/z520 [M1]; HR-FABMS: C21H28O7S4
requires m/z520.0718 [M1]; found: 520.0711. Anal.
calcd for C21H28O7S4: C 48.44, H 5.42; found: C 48.35, H
5.30.
1
5.2. Complex formed between 2´4PF6 and BPP34C10
line oil. H NMR (CDCl3): d1.49 (s, 36H, CH3), 3.89 (s,
8H, SCH2), 4.39 and 4.42 (two br, both 8H, NCH2), 7.09±
7.35 (m, 36H, Ph); FABMS: m/z1570 [M12H]1. Anal.
calcd for C86H96N4O8S8: C 65.78, H 6.16, N 3.57; found: C
65.33, H 6.18, N, 3.44.
The salt 2´4PF6 was extracted into a solution of BPP34C10
(ca. 20 mg) in CD2Cl2 (ca. 1 mL), until no more could be
1
dissolved. The solution was ®ltered and subjected to H
NMR spectral measurement, and the ratio between 2´4PF6
and BPP34C10 was determined from the integrals
5.1.7. 4,5-[Benzene-1,2-dioxybis(ethane-1,2-diyl)dioxy-
bis(ethane-1,2-diyl)dioxybis(ethane-1,2-diyl)bisthio]-1,3-
dithiole-2-thione (13). To a solution of 5 (0.777 g,
2.55 mmol) in MeCN (40 mL) and DMF (10 mL) was drop-
wise added a solution of CsOH´H2O (0.900 g, 5.36 mmol) in
methanol (15 mL) over 10 min. After stirring for 1 h, this
solution and a solution of 8 (1.516 g, 2.55 mmol) in MeCN
(65 mL) were added simultaneously to a solution of MeCN
(100 mL) during 11 h under high dilution conditions by
means of a two-syringe perfusor pump. Stirring was con-
tinued for an additional 2 h, whereupon the reaction mixture
was concentrated in vacuo. Then CH2Cl2 (200 mL) was
added, and the solution was washed with water (200 mL),
dried (MgSO4), and concentrated in vacuo. Column
chromatography [CH2Cl2/EtOAc 5:1] afforded 13
(0.657 g, 48%) as a yellow solid. Mp. 99±1008C. 1H
NMR (CDCl3): d3.08 (t, J5.9 Hz, 4H, SCH2), 3.66±
3.68 (m, 4H, OCH2), 3.75 (t, J5.9 Hz, 4H, OCH2), 3.78±
3.80 (m, 4H, OCH2), 3.90 (t, J4.5 Hz, 4H, OCH2), 4.16 (t,
J4.5 Hz, 4H, OCH2), 6.90 (2£s, 4H, cat.); 1H NMR
(CD2Cl2): d3.06 (t, J6.0 Hz, 4H, SCH2), 3.61±3.63
(m, 4H, OCH2), 3.71±3.73 (m, 8H, OCH2), 3.83 (t, J
4.5 Hz, 4H, OCH2), 4.10 (t, J4.5 Hz, 4H, OCH2), 6.88
(s, 4H, cat.); 13C NMR (CDCl3): d36.39 (SCH2), 69.24
(OCH2), 69.71 (OCH2), 69.93 (OCH2), 70.79 (OCH2), 70.93
(OCH2), 114.35 (cat.), 121.53 (cat.), 136.77 (CvC), 148.91
(cat.), 211.20 (CvS); FABMS: m/z538 [M12H]1; HR-
FABMS: C21H28O6S5 requires m/z536.04895 [M1H1];
found: 536.0493. Anal. calcd for C21H28O6S5: C 46.99, H
5.26; found: C 46.94, H 5.18.
1
(1:1.8,1:2). H NMR (CD2Cl2): d3.23 (br s), 3.33 (br
s), 3.64 (br s), ,3.7 (very br, position determined by
COSY, NCH2), 3.94 (br s) [3.23±3.94 (80H, SCH2, OCH2,
NCH2)], 4.47 (br s, 8H, NCH2), 6.74 (br s), 6.84 (br s), 6.84±
7.47 (br), 7.47 (m), 7.55 (s), 7.56 (s), 7.60 (br s, NH2) [6.74±
7.60 (60H, Ph, OPhO, NH2)]; ESMS: m/z561 [1:2 com-
plex24PF6]41, 617.7 [1:1 complex23PF6]31, 796.3 [1:2
complex23PF6]31, 999 [1:1 complex22PF6]21, 1267 [1:2
complex22PF6]21
.
5.3. Complex formed between 3 and 1´PF6
The salt 1´PF6 was extracted into a solution of 3 in CD2Cl2
until no more could be dissolved. The solution was ®ltered
and subjected to 1H NMR, and the ratio between 3 and 1´PF6
1
was determined from the integrals (1:2.1,1:2). H NMR
(CD2Cl2): d2.98 (br, ca. 1H, SCH2 u), 3.15 (t, J4.8 Hz,
ca. 7H, SCH2 c), 3.42±3.43 (m), 3.58 (t, J2.8 Hz), 3.64±
3.66 (m), 3.81 (t, J4.8 Hz) [3.42±3.81 (32H, OCH2 u/c)],
3.93 (t, J2.8 Hz, 7H, OCH2 c), 4.11 (br, ca. 1H, OCH2 u),
4.26 (s, ca. 1H, NCH2 u), 4.71 (t, J6.7 Hz, ca. 7H, NCH2
c), 6.61 (dd, J3.6 and 6.0 Hz, ca. 3.5H, cat. c), 6.84 (dd,
J3.5 and 6.0 Hz, ca. 3.5H, cat. c), 6.89 (br, ca. 1H, cat. u),
7.22 (t, J3.1 Hz, ca. 10H, Ph c), 7.37±7.43 (m, ca. 10H, Ph
u/c), 7.80 (br, 4H, NH2); FABMS: m/z1206 [1:1 complex-
PF6]1; ESMS: m/z702 [1:2 complex22PF6]21, 1206 [1:1
complex2PF6]1.
5.4. Complex formed between 13 and 1´PF6
5.1.8. 4,5-[Benzene-1,2-dioxybis(ethane-1,2-diyl)dioxy-
bis(ethane-1,2-diyl)dioxybis(ethane-1,2-diyl)bisthio]-1,3-
dithiole-2-one (14). To a solution of 13 (0.524 g,
0.98 mmol) in CHCl3 (75 mL) and glacial acetic acid
(30 mL) was added Hg(OAc)2 (0.778 g, 2.44 mmol), where-
upon the solution was stirred for 3 h. Then it was ®ltered on
Celite, and the Celite layer was rinsed with CHCl3
(100 mL). The ®ltrate was washed with NaHCO3 (aq)
until no more CO2-evolution was observed, and then ®nally
with water (200 mL). The organic phase was dried
(MgSO4), and concentrated in vacuo. Column chroma-
tography [CH2Cl2/EtOAc 5:1] afforded 14 (0.373 g, 73%)
Concentrations in CD2Cl2: [13][1´PF6]0.0097 M. 1H
NMR (CD2Cl2): d3.06 (t, J5.7 Hz, ca. 0.7H, SCH2 u),
3.20 (t, J5.1 Hz, ca. 3.3H, SCH2 c), 3.46±3.48 (m), 3.58±
3.62 (m), 3.68±3.71 (m), 3.83±3.86 (m) [3.46±3.86 (16H,
OCH2 c/u)], 3.94 (t, J3.8 Hz, ca. 3.3H, OCH2 c), 4.11 (br t,
ca. 0.7H, OCH2 u), 4.28 (s, ca. 0.7H, NCH2 u), 4.71 (t, J
6.9 Hz, ca. 3.3H, NCH2 c), 6.61 (dd, J3.5 and 6.0 Hz, ca.
1.65H, cat. c), 6.85 (dd, J3.5 and 6.0 Hz, ca. 1.65H, cat. c),
6.89 (br s, ca. 0.7H, cat. u), 7.23±7.25 (m, ca. 4.8H, Ph c),
7.38±7.41 (m), 7.45 (br s) [7.38±7.45 (ca. 5.2H, Ph c/u)],
7.88 (br, 2H, NH2); FABMS: m/z734 [M2PF6]1; ESMS:
m/z734 [M2PF6]1.
1
as a white solid. Mp 101.5±102.58C. H NMR (CDCl3):
d3.05 (t, J6.1 Hz, 4H, SCH2), 3.66±3.68 (m, 4H,